Hope for knee osteoarthritis sufferers with advent of global clinical trial.
MELBOURNE, Australia, May 24, 2023 /PRNewswire/ -- With the launch of a new website dedicated to their global clinical trials (https://hope4OA.com), Paradigm Biopharmaceuticals Ltd. (Paradigm Biopharma) aims to provide relief to millions of osteoarthritis (OA) sufferers worldwide by developing a new injectable drug.
- Due to their weight bearing role, 70% of all cases affect the hip or the knee.
- Ex-Australian Football League (AFL) player Greg 'Diesel' Williams understands all too well how knee OA can have a devastating impact on your life.
- Dr Philip Bloom comments "Osteoarthritis of the knee is not just an isolated pain in the knee.
- Paradigm Biopharma aims to provide hope to OA sufferers by developing a drug to help relieve pain and improve symptoms in people with knee OA.